State Street Corp Codex Dna, Inc. Transaction History

State Street Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$1.7 - $2.36 $27,837 - $38,645	-16,375 Reduced 42.89%	21,800 $36,000
Q2 2022 Aug 15, 2022	SELL	$1.8 - $6.45 $283,357 - $1.02 Million	-157,421 Reduced 80.48%	38,175 $69,000
Q1 2022 May 16, 2022	BUY	$4.12 - $10.36 $201,410 - $506,458	48,886 Added 33.32%	195,596 $1.05 Million
Q4 2021 Feb 14, 2022	BUY	$6.31 - $11.96 $473,811 - $898,064	75,089 Added 104.84%	146,710 $1.58 Million
Q3 2021 Nov 15, 2021	BUY	$10.15 - $19.88 $726,953 - $1.42 Million	71,621 New	71,621 $797,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.